Skip to main
MYO

Myomo (MYO) Stock Forecast & Price Target

Myomo (MYO) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Myomo is a wearable medical robotics company that has great potential for growth, due to the recent positive Medicare ruling expanding their market reach. With their MyoPro products and strong commercialization efforts, Myomo estimates a $10 billion addressable market in the U.S. alone, providing a high reward for the risks involved. Additionally, the company has a strong balance sheet and has raised their guidance for future revenue, showing positive growth and potential for the company.

Bears say

Myomo is facing strong headwinds in the market, with only a narrow margin of revenue growth in Q1 2026 and continued losses in EPS. The company also faces significant risks, including balance sheet and liquidity concerns, challenges in gaining regulatory approvals and commercializing products, and intense competition in the industry. Additionally, external factors such as changing market conditions and investor sentiment may impact the company's performance.

Myomo (MYO) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Myomo (MYO) Forecast

Analysts have given Myomo (MYO) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Myomo (MYO) has a Strong Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Myomo (MYO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.